4D Molecular Therapeutics, Inc. (FDMT)
10.46
-0.33
(-3.06%)
USD |
NASDAQ |
Nov 18, 16:00
10.46
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Total Assets (Quarterly) : 428.75M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 428.75M |
| June 30, 2026 | 492.62M |
| March 31, 2026 | 512.90M |
| December 31, 2025 | 566.71M |
| September 30, 2025 | 423.98M |
| June 30, 2025 | 473.64M |
| March 31, 2025 | 515.73M |
| December 31, 2024 | 560.38M |
| September 30, 2024 | 604.03M |
| June 30, 2024 | 620.12M |
| March 31, 2024 | 629.88M |
| December 31, 2023 | |
| September 30, 2023 | 361.61M |
| June 30, 2023 | 352.50M |
| Date | Value |
|---|---|
| March 31, 2023 | 244.02M |
| December 31, 2022 | 261.85M |
| September 30, 2022 | 280.16M |
| June 30, 2022 | 302.94M |
| March 31, 2022 | 324.93M |
| December 31, 2021 | 353.49M |
| September 30, 2021 | 240.62M |
| June 30, 2021 | 254.93M |
| March 31, 2021 | 270.11M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 58.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 189.60M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
| Imunon, Inc. | 12.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.81M |
| Shareholders Equity (Quarterly) | 337.94M |
| Debt to Equity Ratio | 0.1137 |
| Current Ratio | 6.151 |
| Net Debt Paydown Yield | -0.38% |